Slava Elagin, Ph.D., MBA brings 30 years of experience in life sciences, biotechnology, business leadership, organizational management and scientific innovation to his role as MiraVista’s Chief Operations Officer (COO).
In this leadership capacity, Dr. Elagin works with the company’s President and Board to define MiraVista’s long-range vision, identify and address emerging market trends, set quantifiable business objectives and lead strategic growth initiatives. Dr. Elagin oversees day-to-day operations and works with MiraVista’s management team to drive company growth through development and execution of corporate-wide strategies within and across the company’s departments and operational/ administrative functions.
Dr. Elagin’s offers deep expertise in the areas of molecular diagnostics, clinical research, IVD product development, medical device regulations and clinical laboratory management. Prior to joining MiraVista, Dr. Elagin served as Executive Vice President and Chief Scientific Officer for Meridian Bioscience, Inc. where he led the research and development function for the global publically-traded corporation. Before this position, he held executive leadership roles with Third Wave Technologies and EraGen Biosciences.
Dr. Elagin holds a Ph.D. in molecular genetics and Master of Business Administration in finance. He is the inventor on ten U.S. patents and the author of several dozen peer-reviewed scientific publications.